product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human Glypican 1 Protein, CF
catalog :
4519-GP-050
quantity :
50 ug
price :
432 USD
more info or order :
citations: 8
Reference
Shibata R, Konishi H, Arita T, Yamamoto Y, Matsuda H, Yamamoto T, et al. Extracellular glypican-1 affects tumor progression and prognosis in esophageal cancer. Cancer Med. 2024;13:e70212 pubmed publisher
Li N, Quan A, Li D, Pan J, Ren H, Hoeltzel G, et al. The IgG4 hinge with CD28 transmembrane domain improves VHH-based CAR T cells targeting a membrane-distal epitope of GPC1 in pancreatic cancer. Nat Commun. 2023;14:1986 pubmed publisher
Cao Y, Wu J, Zheng X, Lu Y, Piper J, Lu Y, et al. Assessing the activity of antibodies conjugated to upconversion nanoparticles for immunolabeling. Anal Chim Acta. 2022;1209:339863 pubmed publisher
Colin Pierre C, Untereiner V, Sockalingum G, Berthelemy N, Danoux L, Bardey V, et al. Hair Histology and Glycosaminoglycans Distribution Probed by Infrared Spectral Imaging: Focus on Heparan Sulfate Proteoglycan and Glypican-1 during Hair Growth Cycle. Biomolecules. 2021;11: pubmed publisher
Lund M, Howard C, Thurecht K, Campbell D, Mahler S, Walsh B. A bispecific T cell engager targeting Glypican-1 redirects T cell cytolytic activity to kill prostate cancer cells. BMC Cancer. 2020;20:1214 pubmed publisher
Asega A, Menezes M, Trevisan Silva D, Cajado Carvalho D, Bertholim L, Oliveira A, et al. Cleavage of proteoglycans, plasma proteins and the platelet-derived growth factor receptor in the hemorrhagic process induced by snake venom metalloproteinases. Sci Rep. 2020;10:12912 pubmed publisher
Nishigaki T, Takahashi T, Serada S, Fujimoto M, Ohkawara T, Hara H, et al. Anti-glypican-1 antibody-drug conjugate is a potential therapy against pancreatic cancer. Br J Cancer. 2020;122:1333-1341 pubmed publisher
Gao W, Xu Y, Liu J, Ho M. Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate. Sci Rep. 2016;6:26245 pubmed publisher
product information
master code :
4519-GP
SKU :
4519-GP-050
product name :
Recombinant Human Glypican 1 Protein, CF
unit size :
50 ug
description :
The Recombinant Human Glypican 1 Protein, CF from R&D Systems is derived from NS0. The Recombinant Human Glypican 1 Protein, CF has been validated for the following applications: Binding Activity.
target :
Glypican 1
category :
Proteins and Enzymes
buffer :
Lyophilized from a 0.2 ╡m filtered solution in PBS.
conjugate :
Unconjugated
purity :
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain
species :
Human
observed molecular weight :
60 kDa, reducing conditions
theoretical molecular weight :
56.8 kDa
gene symbol :
GPC1
details of functionality :
Measured by its binding ability in a functional ELISA. Immobilized rhGlypicaná1 at 3á╡g/mL (100 ╡L/well) will bind rhFGF-basic with an apparent KDá á1ánM.
endotoxin note :
<0.10 EU per 1 ╡g of the protein by the LAL method.
accessionNumbers :
P35052
applications :
Binding Activity
source long :
Mouse myeloma cell line, NS0-derived human Glypican 1 protein Asp24-Ser530, with a C-terminal 6-His tag
source short :
NS0
USD :
432 USD
alt names :
FLJ38078, glypican, glypican 1, glypican proteoglycan 1, glypican-1, GPC1
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.